Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04817683
Other study ID # 2020024
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2020
Est. completion date December 28, 2020

Study information

Verified date March 2021
Source Second Affiliated Hospital of Xi'an Jiaotong University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A cross-sectional study was conducted to collect the relevant data of college students' mobile phone addiction and FGIDs (IBS, FD) in the form of questionnaire, so as to understand the situation of college students' mobile phone addiction and the incidence of FGIDs (IBS and FD), and explore the correlation, so as to provide new ideas and scientific basis for the prevention, diagnosis and treatment of FGIDs among college students.


Description:

This study adopts the method of cross-sectional survey to collect the relevant data of Chinese college students' mobile phone addiction and FGIDs (IBS, FD) in the form of online and face-to-face questionnaire, so as to understand the situation of Chinese college students' mobile phone addiction and the incidence of FGIDs (IBS, FD), and explore the correlation, so as to provide new ideas and scientific basis for the prevention, diagnosis and treatment of FGIDs.


Recruitment information / eligibility

Status Completed
Enrollment 3000
Est. completion date December 28, 2020
Est. primary completion date December 28, 2020
Accepts healthy volunteers
Gender All
Age group 17 Years and older
Eligibility Inclusion Criteria: - College students from all over the country, over 17 years old, have a physical examination before entering school - Sign the informed consent form, voluntarily participate and fill in the questionnaire Exclusion Criteria: - People with diabetes, hyperthyroidism or hypothyroidism, peptic ulcer, inflammatory bowel disease, digestive tract tumor or severe medical and surgical disease - History of abdominal surgery (such as esophagus, stomach, small intestine, colon, rectum, appendix, gallbladder, hysterectomy, cesarean section) - Recently, there are some alarm symptoms, such as relieving black stool, bloody stool, hematemesis, abnormal anemia, fever, abnormal weight loss (no intention to lose weight, weight loss 5 kg in 3 months), change of defecation habits, dysphagia and so on - In the past 4 weeks, he has taken drugs that affect the judgment of gastrointestinal symptoms, such as anti-inflammatory painkillers, diazepam drugs, anti-anxiety drugs, depressants and so on

Study Design


Locations

Country Name City State
China The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital of Xi'an Jiaotong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of irritable bowel syndrome among College Students.Risk factors of irritable bowel syndrome. The irritable bowel syndrome was diagnosed by the Rome IV diagnostic questionnaire, and then the incidence of irritable bowel syndrome was calculated by SPSS. Through PHQ-9 questionnaire to diagnose depression, GAD-7 questionnaire to diagnose anxiety, MPAI questionnaire to diagnose mobile phone addiction, AIS questionnaire to diagnose insomnia, logistic regression analysis to calculate OR value and P value, to understand the relationship between irritable bowel syndrome and anxiety, depression, insomnia, mobile phone addiction. 2020.07.03-2020.12.28
Secondary Incidence of functional dyspepsia among College Students.Risk factors of functional dyspepsia. The functional dyspepsia was diagnosed by the Rome IV diagnostic questionnaire, and then the incidence of functional dyspepsia was calculated by SPSS. Through PHQ-9 questionnaire to diagnose depression, GAD-7 questionnaire to diagnose anxiety, MPAI questionnaire to diagnose mobile phone addiction, AIS questionnaire to diagnose insomnia, logistic regression analysis to calculate OR value and P value, to understand the relationship between functional dyspepsia and anxiety, depression, insomnia, mobile phone addiction. 2020.07.03-2020.12.28
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05118243 - Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance N/A
Completed NCT04422327 - The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome Phase 1/Phase 2
Recruiting NCT05178017 - Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS) N/A
Completed NCT05197413 - Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms N/A
Completed NCT04905524 - Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP) N/A
Recruiting NCT06297785 - Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS) N/A
Recruiting NCT05874830 - The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome N/A
Active, not recruiting NCT04723056 - Zemedy Application for Irritable Bowel Syndrome N/A
Completed NCT05565612 - Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome N/A
Recruiting NCT03131414 - The IMAGINE-SPOR CIHR Chronic Disease Network
Completed NCT03333291 - Fecal Transplantation in Patients With IBS N/A
Completed NCT03449628 - L. Casei DG® in Patients With Irritable Bowel Syndrome. N/A
Recruiting NCT06215222 - Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
Completed NCT05016596 - Postprandial Lipids in IBS and Nutritional Treatment N/A
Recruiting NCT04760353 - The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome N/A
Completed NCT06426745 - Split-dose Versus Single-dose Bowel Preparation for Colonoscopy N/A
Recruiting NCT04217733 - Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome Phase 3
Completed NCT03178877 - The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors N/A
Recruiting NCT05990764 - Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS) N/A
Completed NCT03948854 - Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients N/A